Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

Crave JC, Fimbel S, Lejeune H, Cugnardey N, Déchaud H, Pugeat M.

J Clin Endocrinol Metab. 1995 Jul;80(7):2057-62.

PMID:
7608255
2.

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.

PMID:
10946879
3.

[Hyperandrogenism in hirsute and obese women. Effects of a low calorie diet].

Nicolas MH, Crave JC, Fimbel S, Siméan A, Pugeat M.

Presse Med. 1993 Jan 2-16;22(1):19-22. French.

PMID:
8469656
4.

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.

Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.

Gynecol Endocrinol. 2002 Jun;16(3):217-24.

PMID:
12192894
5.

Beneficial effects of metformin in normoglycemic morbidly obese adolescents.

Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.

Metabolism. 2001 Dec;50(12):1457-61.

PMID:
11735093
6.

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

Gambineri A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R.

Clin Endocrinol (Oxf). 2004 Feb;60(2):241-9.

PMID:
14725687
7.

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R.

J Clin Endocrinol Metab. 2006 Oct;91(10):3970-80.

PMID:
16868063
8.

Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.

Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A.

Diabetes Obes Metab. 2004 May;6(3):208-15.

PMID:
15056129
9.

Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

Vermeulen A, Kaufman JM, Giagulli VA.

J Clin Endocrinol Metab. 1996 May;81(5):1821-6.

PMID:
8626841
10.

Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women.

Reinecke H, Bogdanski J, Woltering A, Breithardt G, Assmann G, Kerber S, von Eckardstein A.

Am J Cardiol. 2002 Aug 15;90(4):364-8.

PMID:
12161223
11.

The effects of metformin and diet on plasma testosterone and leptin levels in obese men.

Ozata M, Oktenli C, Bingol N, Ozdemir IC.

Obes Res. 2001 Nov;9(11):662-7.

12.

Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.

Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.

Clin Endocrinol (Oxf). 1992 Feb;36(2):197-202.

PMID:
1533185
13.

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG.

J Clin Endocrinol Metab. 1991 Jan;72(1):83-9.

PMID:
1898744
15.

Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?

Korytkowski MT, Krug EI, Daly MA, Deriso L, Wilson JW, Winters SJ.

Metabolism. 2005 Dec;54(12):1626-31.

PMID:
16311096
16.

Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.

Montalto J, Whorwood CB, Funder JW, Yong AB, Callan A, Davies HE, Connelly JF.

Clin Endocrinol (Oxf). 1990 Jan;32(1):1-12.

PMID:
2139595
19.

Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.

Marena S, Tagliaferro V, Montegrosso G, Pagano A, Scaglione L, Pagano G.

Diabete Metab. 1994 Jan-Feb;20(1):15-9.

PMID:
8056129
20.

[Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].

Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.

Zhonghua Fu Chan Ke Za Zhi. 2003 Dec;38(12):745-8. Chinese.

PMID:
14728846
Items per page

Supplemental Content

Support Center